市場調查報告書
商品編碼
1360059
北美拋棄式內視鏡市場預測至2028 年- 區域分析- 按應用(胃腸內視鏡檢查、支氣管鏡檢查、泌尿科內視鏡檢查、關節鏡檢查、直腸鏡檢查等)和最終用戶(醫院、診斷中心和診所)North America Disposable Endoscope Market Forecast to 2028 -Regional Analysis - by Application (GI Endoscopy, Bronchoscopy, Urologic Endoscopy, Arthroscopy, Proctoscopy, and Others) and End User (Hospitals, Diagnostic Centers, and Clinics) |
北美拋棄式內視鏡市場預計將從2022年的5.3215億美元成長到2028年的13.7508億美元;預計2022年至2028年年複合成長率為17.1%。
對病人安全和工作流程效率的日益關注促進了北美拋棄式內視鏡市場的成長
近年來,人們越來越意識到可重複使用的內視鏡可能在患者之間攜帶有害生物,從而帶來交叉污染的風險。關於可重複使用的內視鏡,FDA 透過發布安全通報並強調肺病學、泌尿學、耳鼻喉科和胃腸病學的風險,強化了其指導方針。此外,在過去幾年中,與泌尿科、耳鼻喉科和胃腸病學領域的內視鏡使用相關的可重複使用內視鏡召回和安全警告增加。醫療器材促進協會 (AAMI) 將肺部、泌尿科和胃腸道內視鏡列為高風險,並制定了高度嚴格的清潔指南,這增加了可重複使用內視鏡的成本和複雜性。
醫院系統中的可重複使用內視鏡需要複雜的後處理設備,包括乾燥設備和訓練有素的工作人員。此外,再處理延遲、設備停機、內視鏡損壞和人員短缺可能會導致手術延遲和其他效率低下,對病患照護產生負面影響。然而,拋棄式內視鏡是無菌的且易於取得。
它們不需要複雜的後處理基礎設施,減少了勞動力和資本密集度,而可重複使用的內視鏡既是資本也是勞動力密集。隨著醫療保健專業人員尋求高性能和直覺的內視鏡解決方案,以提高患者安全性,提供切實的工作流程和效率優勢,並融入最新的技術進步,對拋棄式內視鏡的需求持續快速成長。
因此,由於對病患安全和工作流程效率的日益關注,北美拋棄式內視鏡市場正在快速成長。
北美拋棄式內視鏡市場概況
北美拋棄式內視鏡市場分為美國、加拿大和墨西哥。該地區的市場成長歸因於慢性病盛行率的增加、政府支持的增加以及一次性內視鏡市場的產品開發。在美國,由於胃腸道疾病和癌症病例的增加,拋棄式內視鏡正在被迅速採用和銷售。由於呼吸系統疾病和慢性疾病的盛行率不斷上升,內視鏡手術在美國變得越來越受歡迎,這將在預測期內推動該國拋棄式內視鏡市場的成長。
北美拋棄式內視鏡市場收入及2028年預測(百萬美元)
北美拋棄式內視鏡市場細分
北美拋棄式內視鏡市場根據應用、最終用戶和國家進行細分。根據應用,市場分為胃腸內視鏡、支氣管鏡、泌尿道內視鏡、關節鏡、直腸鏡等。胃腸道內視鏡細分市場在 2022 年佔據最大的市場。
根據最終用戶,北美拋棄式內視鏡市場分為醫院、診斷中心和診所。 2022 年,醫院細分市場佔據最大市場佔有率。
按國家/地區分類,北美拋棄式內視鏡市場分為美國、加拿大和墨西哥。 2022年,美國在北美拋棄式內視鏡市場佔有率中佔據主導地位。
Boston Scientific Corp、Ambu AS、Consis Medical Ltd、Hill-Rom Services Inc.、Karl Storz SE & Co KG、Flexicare (Group) Ltd、OBP Medical Corp、Prosurg Inc. 和Coloplast Corp 是在該領域營運的領先公司之一。北美拋棄式內視鏡市場。
The North America disposable endoscope market is expected to grow from US$ 532.15 million in 2022 to US$ 1,375.08 million by 2028; it is estimated to record a CAGR of 17.1% from 2022 to 2028.
Increased Focus on Patient Safety and Workflow Efficiency Bolsters North America Disposable Endoscope Market Growth
In recent years, there has been a growing awareness about the risk of cross-contamination due to reusable endoscopes which can carry harmful organisms among patients. With regard to reusable endoscopy, FDA has intensified its guidelines by issuing safety communications and highlighting risks across pulmonology, urology, ENT, and gastroenterology. Furthermore, over the past few years, there has been an increase in reusable endoscope recalls and safety warnings related to endoscope use in the urology, ENT, and gastroenterology branches. The Association for the Advancement of Medical Instrumentation (AAMI) has classified pulmonology, urology, and GI endoscopes as high-risk and has put in place highly stringent cleaning guidelines, which has increased the cost and the complexity of reusable endoscopy.
Reusable endoscope in the hospital systems requires complex reprocessing equipment, including drying equipment, and trained staff. Further, reprocessing delays, equipment downtime, endoscope breaks, and staff shortages can result in procedure delays and other inefficiencies, which can negatively impact patient care. However, single-use endoscopes are sterile and easily available.
They do not require complex reprocessing infrastructure reduces both labor and capital intensity whereas reusable endoscopes are both capital- and labor-intensive. Demand for single-use endoscopes continues to grow rapidly as healthcare professionals seek high-performing and intuitive endoscopy solutions that enhance patient safety, provide tangible workflow and efficiency benefits, and incorporate the latest technology advances.
Thus, due to an increasing focus on patient safety and workflow efficiency, the North America disposable endoscope market is growing at a rapid pace.
North America Disposable Endoscope Market Overview
The North America disposable endoscope market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the increasing prevalence of chronic illnesses, rising government support, and product development in disposable endoscope market. In the US, disposable endoscopes are being adopted and marketed rapidly due to an increase in cases of gastrointestinal disorders and cancer. Endoscopic procedures have become increasingly popular in the US due to growing prevalence of respiratory and chronic illnesses, which will boost the disposable endoscope market growth in this country during the forecast period.
North America Disposable Endoscope Market Revenue and Forecast to 2028 (US$ Million)
North America Disposable Endoscope Market Segmentation
The North America disposable endoscope market is segmented on the basis of application, end user, and country. Based on application, the market is segmented into GI endoscopy, bronchoscopy, urologic endoscopy, arthroscopy, proctoscopy, and others. The GI endoscopy segment held the largest market share in 2022.
Based on end user, the North America disposable endoscope market is segmented into hospitals, diagnostic centers, and clinics. The hospitals segment held the largest market share in 2022.
Based on country, the North America disposable endoscope market is segmented into the US, Canada, and Mexico. The US dominated the North America disposable endoscope market share in 2022.
Boston Scientific Corp, Ambu AS, Consis Medical Ltd, Hill-Rom Services Inc., Karl Storz SE & Co KG, Flexicare (Group) Ltd, OBP Medical Corp, Prosurg Inc., and Coloplast Corp are among the leading companies operating in the North America disposable endoscope market.